-
Tuesday, June 4, 2024
The USC Roski Eye Institute is at the forefront of three separate clinical trials exploring new medications to treat thyroid eye disease (TED), a condition that causes the eyes to bulge and leads to vision loss, double vision and other complications. Prior to a few years ago, no medication for... Read More »
-
Tuesday, June 4, 2024
Paula Cannon, PhD, Distinguished Professor of Molecular Microbiology & Immunology with the Keck School of Medicine of USC, has become the president of the American Society of Gene and Cell Therapy (ASGCT), the world’s largest organization devoted to developing next-generation therapies that address the underlying causes of disease. Established in... Read More »
-
Wednesday, May 29, 2024
On May 28, Paul Krekorian, president of the Los Angeles City Council, recognized May 2024 as Brain Tumor Awareness Month for the first time in the city’s history and honored the USC Brain Tumor Center, part of Keck Medicine of USC, whose advocacy efforts played a large role in the... Read More »
-
Wednesday, May 29, 2024
The California Institute for Regenerative Medicine (CIRM), California's state stem cell agency, has appointed Carolyn Meltzer, MD, dean of the Keck School of Medicine of USC, to its leadership board. She joins 35 Californians — including patients, advocates, researchers, educators and professionals from the biotechnology industry — who each have... Read More »
-
Tuesday, May 28, 2024
Angel Arizpe, MPH, a third year PhD student in the epidemiology program, has been awarded $10,000 from the Healthy Americas Research Consortium (HARC) Todos Juntos Grants to support his research on cancer-related health disparities faced by Hispanic communities in the United States. Arizpe will also have access to data sets... Read More »
-
Tuesday, May 28, 2024
Among the aims of the Inflation Reduction Act (IRA), one is to reduce health care costs for older adults by eliminating cost sharing for certain drugs and vaccines covered by Medicare Part D. To help determine if the impact matches the IRA’s intent, a team led by Dima Qato, PharmD,... Read More »
-
Tuesday, May 21, 2024
Serghei Mangul, PhD, assistant professor of clinical pharmacy and quantitative and computational biology at the USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, has earned a Fulbright U.S. Scholar Program award for the 2024–2025 academic year. Sponsored by the U.S. Department of State, the highly competitive Fulbright awards support... Read More »
-
Tuesday, May 21, 2024
Researchers at the Keck School of Medicine of USC have found that a 0.68 milligram per liter increase in fluoride exposure may nearly double the chance of a child showing neurobehavioral problems in a range considered close to or at a level to meet the criteria for clinical diagnosis. The... Read More »
-
Friday, May 17, 2024
A researcher from the Keck School of Medicine of USC has discovered a potential breakthrough in delaying the onset of Alzheimer’s and Parkinson’s disease and treating hydrocephalus. Young-Kwon Hong, PhD, the chief of basic science research for the Keck School's Department of Surgery, and his team have developed a drug... Read More »
-
Thursday, May 16, 2024
Readers of USC Health, Keck Medicine of USC’s patient- and community-facing magazine, can find the latest issue online at KeckMedicine.org/magazine. Print copies are also en route to Keck Medicine clinical locations and mailboxes across southern California. In this issue, readers will meet Cora Jackson-Fossett, a lifelong spokesperson who needed a... Read More »
-
Wednesday, May 15, 2024
A new Keck Medicine of USC study published in Leukemia Research suggests that a bone marrow transplant from a haploidentical (half-identical) relative may greatly increase patients’ odds of success, in addition to being easier to find. Patients who received their transplant from a half-identical relative were about 70% more likely to avoid... Read More »